Status:
UNKNOWN
Linear Growth of Children With Congenital Adrenal Hyperplasia
Lead Sponsor:
Assiut University
Conditions:
Congenital Adrenal Hyperplasia
Eligibility:
All Genders
1-18 years
Brief Summary
The congenital adrenal hyperplasias (CAHs) comprise a family of autosomal recessive disorders that disrupt adrenal steroidogenesis. Three specific enzyme deficiencies are associated with virilization ...
Detailed Description
It has been reported that approximately one child in every 18000 born in Great Britain has CAH. In North America, the incidence varies from 1:15000 to 1:16000. The reported rates of CAH have been as h...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age: 1-18 y.
- Both sexes.
- All patients who were diagnosed as having CAH of at least 1 y duration.
- On glucocorticoid replacement therapy .
- Exclusion criteria:
- Patients diagnosed as CAH for less than 1 year duration.
- Patients with deficient data at the time of diagnosis.
- Patients missed for follow up.
- Syndromatic patients.
Exclusion
Key Trial Info
Start Date :
September 24 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 24 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04087148
Start Date
September 24 2019
End Date
October 24 2021
Last Update
September 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.